GlaxoSmithKline
-
Ottawa announces influenza vaccine agreement with GlaxoSmithKlineThe deal includes an option to procure 80 million doses of influenza vaccine if a pandemic occurs and a minimum of four million doses annually.HealthJul 15, 2022
-
Standard drugs used to fight COVID-19 may not work against Omicron: U.S. doctorsThe shrinking toolbox of treatments is a painful reminder that COVID-19 still has the upper hand in the U.S., even with more than 200 million Americans fully vaccinated.HealthDec 19, 2021
-
-
Advertisement
-
Sanofi’s COVID-19 vaccine sees up to 100% efficacy in latest trialThe robust immune response results enable Sanofi and GlaxoSmithKline to move to a late-stage study, the French drugmaker said.WorldMay 17, 2021
-
-
Advertisement
-
Canada’s Medicago begins late-stage study of COVID-19 vaccine with GlaxoSmithKlineMedicago, which has Canada's most advanced COVID-19 vaccine project under development, expects to report results from a mid-stage trial of the vaccine in April.CanadaMar 16, 2021
-
Drugmakers partner to develop COVID-19 vaccines aimed at new variantsThe announcement comes as public health officials around the world raise concerns about new virus variants that are more contagious or resistant to existing vaccines.WorldFeb 3, 2021
-
-
Canada has approved 2 coronavirus vaccines. How are other candidates progressing?Here's where each of the vaccine candidates not yet approved by Health Canada currently stand in the development and review processes.HealthDec 24, 2020
-
-
Two drugmakers say their coronavirus vaccine won’t be ready until late 2021"The results of the study are not as we hoped," Roger Connor, president of GSK Vaccines, said in a statement.WorldDec 11, 2020
-
Flu shot batch under review, Manitoba not reporting serious side effectsA flu shot that was sent to Manitoba health-care providers is being shelved pending a safety review, but experts say it shouldn’t deter you from getting a shot this year.HealthNov 18, 2020
-
-
Advertisement
-
Trump to name former pharmaceutical exec to lead U.S. coronavirus vaccine pushMoncef Slaoui, a former GlaxoSmithKline executive, will lead “Operation Warp Speed,” Trump’s push to accelerate the vaccine development process for COVID-19, according to an administration official.HealthMay 13, 2020
-
-
Advertisement
-
University of Saskatchewan professor to study marijuana as medicineUniversity of Saskatchewan professor Robert Laprairie aims to gain more insight into the use of marijuana as a medicine.HealthNov 7, 2017
Trending
-
‘Exceptional’ mortgage rates spotted in Canada after U.S. Fed rate cut25,395 Read
-
NDP to join Bloc in backing Liberals against non-confidence vote18,089 Read
-
‘I couldn’t stop crying’: Memorial grows for 5-year-old boy killed in home13,968 Read
-
Some of Canada’s airports are getting CT scanners. Here’s why13,271 Read
-
Mohamed Al-Fayed, whose son died with Princess Diana, accused of multiple rapes11,346 Read
-
Retired Quebec teacher buys winning lottery ticket at last minute, wins $40M9,368 Read
-
Top Videos
-
Raw Video: Police charged with assault after arrest in south Edmonton75 Viewed
-
Rally in Toronto calls for government action, compensation on Grassy Narrows mercury poisoning52 Viewed
-
Doug Ford’s nephew enters cabinet as minister of citizenship and multiculturalism22 Viewed
-
Business Matters: ‘Exceptional’ mortgage rates spotted in Canada after U.S. Fed rate cut22 Viewed
-
U.S. election 2024: Harris seen as debate winner, widens lead over Trump in polls21 Viewed
-
Want to sleep in a $1-million Nova Scotia castle? New owner plans to open grounds to public18 Viewed
-